knowledge -WSS

knowledge

author：hotspot 2025-09-29 07:50:00 - browse：85699

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello, friends! I’m in San Francisco for the STAT Breakthrough Summit. Later today, I’ll be “fireside chatting” with Cytokinetics CEO Robert Blum. It’s not too late to join us virtually. Check out details here.

It’s a travel-shortened week for me, so in this newsletter, I decided to dive deep into PDS Biotech and its experimental drug for head and neck cancer. PDS is what I’d call a biotech cult stock.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Unicorn down: Following layoffs, Biofourmis CEO quietly departs

WSS

How to make AI work for medicine

NYU Langone launches private ChatGPT for its health care data

FDA panel gives mixed vote on blood pressure devices

Changes to biosimilar regulatory framework must prioritize patients

STAT Virtual Event: Putting AI to the Test

Changes to biosimilar regulatory framework must prioritize patients

focus

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

Malaria cases in Florida and Texas: Here’s what you need to know

Microbiome research is starting to find links to chronic diseases

At least 13 dead in Texas as scorching temps continue

How Vertex's cystic fibrosis drug is changing patients' lives

Apple is now the first public company to be valued at $3 trillion

Study finds new variant for Parkinson’s in African populations

United colonoscopy coverage change 'may cost lives,' doctors say

Neuroscience startup Neumora files for IPO

In Memoriam: Notable people who died in 2023

FDA panel to weigh approval of NurOwn, controversial ALS drug

hotspot

Thermo Fisher plant for manufacturing gene therapies to expand

Thermo Fisher plant for manufacturing gene therapies to expand

Readout LOUD podcast: possible new ALS drug, artificial wombs

FDA panel to weigh approval of NurOwn, controversial ALS drug

Feds fine Medicare Advantage plans for overcharging members

CommonSpirit Health keeps growing, even as it loses money

leisure time

knowledge

Wikipedia

entertainment